KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and.
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and gene therapy productsExperienced team of biopharma services veterans led by Thomas Eldered of Flerie Invest AB (“Flerie”).
Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients. MARTINSRIED-MUNICH, Germany, July 31, 2023 / B3C newswire / Cor.
Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new Campus as the next step in its growth strategy .
Coriolis Pharma is substantially expanding its current headquarters with additional facilities to form a new Campus.MARTINSRIED-MUNICH, Germany, June 03, 2022 / B3C newswire / Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation re.